Erenumab is a first-in-class fully human monoclonal CGRP antibody. Erenumab inhibits the calcitonin gene-related peptide (CGRP) receptor. Erenumab can be used for the research of episodic migraine.
CAS Number:
[1582205-90-0]
Target:
CGRP Receptor
* VAT and and shipping costs not included. Errors and price changes excepted